Top 3 Shiba Inu (SHIB) Alternatives Likely to Hit $5B Market Cap by 2027
The post Top 3 Shiba Inu (SHIB) Alternatives Likely to Hit $5B Market Cap by 2027 appeared first on Coinpedia Fintech News As
Stocks
Stocks
3 Best Crypto Presales to Buy Now Before Listing – Digitap ($TAP), BlockDAG, and Pepenode in Spotlight
The post 3 Best Crypto Presales to Buy Now Before Listing – Digitap ($TAP), BlockDAG, and Pepenode in Spotlight appeared first on Coinpedia
Stocks
AAVE Price Prediction 2025: Can Chainlink ACE & DAO Buyback Save AAVE From a $150 Dip?
The post AAVE Price Prediction 2025: Can Chainlink ACE & DAO Buyback Save AAVE From a $150 Dip? appeared first on Coinpedia Fintech
Stocks
UBS and Chainlink Complete World’s First Live Tokenized Fund Transaction
The post UBS and Chainlink Complete World’s First Live Tokenized Fund Transaction appeared first on Coinpedia Fintech News UBS has announced the successful
Investing
ASX 200 Index risky pattern points to a crash after RBA rate decision
The ASX 200 Index continued its downtrend as Australian bond yields jumped after the Reserve Bank of Australia (RBA) delivered its interest rate
Investing
Here’s why South Korea’s KOSPI Index has soared this year
The KOSPI Composite Index remains in a strong bull run this year and is hovering near its all-time high as most South Korean
Investing
IAG share price targets an all-time high ahead of earnings
The IAG share price is nearing its all-time high, continuing an uptrend that started in April when it was trading at 206p. It
Investing
Top reasons the crypto crash is happening as liquidations jump
A crypto crash happened today, with Bitcoin and most altcoins continuing their recent downtrend. Bitcoin price plunged to a low of $104,130, down
Investing
Here’s why the S&P 500 and Dow Jones futures are falling today
The American stock market is falling today, with the Dow Jones, S&P 500, and Nasdaq 100 futures falling by 0.65%, 1%, and 1.28%,
Economy
Kimberly-Clark to buy Kenvue in $48.7 billion deal
Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one